期刊文献+

慢性肾功能衰竭患者外周血单核细胞向树突状细胞分化能力的研究 被引量:5

Differentiation of Monocyte-derived Dendritic cell in patients with chronic renal failure
下载PDF
导出
摘要 目的了解慢性肾功能衰竭患者外周血单核细胞向树突状细胞(DC)分化的能力。方法采用流式细胞仪检测细胞表面标记表达,混合淋巴细胞反应评价细胞的抗原递呈能力。结果慢性肾功能衰竭患者外周血单核细胞能向DC分化,分化而成的DC表达CD11c,CD40,CD80,CD83的阳性率显著低于正常人(P<0.05),刺激淋巴细胞增殖的能力显著弱于正常人(P<0.01)。结论慢性肾功能衰竭患者外周血单核细胞向DC分化的能力减弱,分化而成的DC具有较弱的抗原递呈能力。 Objective: To investigate the differentiation of dendritic cells from monocytes of peripheral blood in patients with chronic renal failure. Methods: The phenotype of monocyte-derived dendritic cells(MoDC) was analyzed using Flow cytometry.The capacity of MoDC to present antigen was evaluated by mixed lymphocyte reaction. Results: Monocytes in the peripheral blood of patients with chronic renal failure could differentiate into dendritic cells. Expression of CD11c, CD40, CD80 and CD83 was significantly decreased in patients with chronic renal failure compared with that in normal controls (P<0.01). The capacity of MoDC to stimulate T lymphocytes was weakened significantly in patients′group as well (P<0.01). Conclusions: The differentiation of Monocytes into Dendritic cells is downregulated in chronic renal failure, and these cells have mild antigen presenting capacities.
出处 《中国现代医学杂志》 CAS CSCD 2004年第20期41-44,共4页 China Journal of Modern Medicine
关键词 慢性肾功能衰竭(CRY) 树突细胞(DC) 细胞分化 单核细胞 chronic renal failure dendritic cells cell differentiation monocytes
  • 相关文献

参考文献7

  • 1Moser B, Roth G, Brunner M, et al .Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis[J]. Biochem Biophys Res Commun,2003,
  • 2Beckebaum S, Cicinnati VR, Zhang X, et al. Hepatitis B virusinduced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune esc ape[J]. Immunology, 2003, 109(4): 487-495.
  • 3Mazariegos GV, Zahorchak AF, Reyes J,et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients [J]. Am J Transplant, 2003, 3(6): 689-696.
  • 4D'Intini V, Bordoni V, Fortunato A, et al. Longitudinal study of apoptosis in chronic uremic patients[J]. Semin Dial, 2003, 16(6):467-473.
  • 5Alscher DM, Bruckner A, Fritz P, et al. Metallothionein and dendritic cells in skin of end-stage renal disease patients not on dialysis, or on hemodialysis or peritoneal dialysis[J]. Perit Dial Int, 2002, 22(4): 449-453.
  • 6卢娟娟,刘骏达,张锦堃,周佩芳.黄芪对慢性肾功能衰竭血树突状细胞的影响[J].中国康复,2001,16(4):204-205. 被引量:21
  • 7王海燕.肾脏病学[M](第2版)[M].北京:人民卫生出版社,2001.1341-1344.

二级参考文献2

共引文献38

同被引文献18

  • 1齐晖,李富荣,肖学吕,任莉莉,刘冬舟,文锦丽,黄瑞芳.系统性红斑狼疮患者外周血中树突状细胞的诱导、培养及与疾病活动指数的相关性[J].中国医学工程,2004,12(5):18-20. 被引量:3
  • 2陈文宽,陈福进,曾宗渊,伍国号,郭朱明,魏茂文,杨安奎,张诠,何洁华,侯景辉.S100标记树突细胞在声门型喉鳞癌癌周组织中的表达及其与预后的关系[J].癌症,2005,24(10):1272-1275. 被引量:5
  • 3孙文学,戴勇,齐晖,李富荣,王新根,刘毅.腹膜透析患者血中树突状细胞数量及活性研究[J].中国中西医结合肾病杂志,2005,6(10):576-579. 被引量:1
  • 4FISHBANE S, KOWALSKI EA, IMBRIANO LJ, et al. The evaluation of iron status in hemodialysis patients [J]. J Am Soc Nephrol, 1996, 7(12): 2654-2657.
  • 5ALLEGRS V, MENGOZZI G, VASILE A, et al. Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments[J]. Nephron, 1991,57(2): 175-182.
  • 6HORL WH, DREYLING K, STEINHAUER HB, ENGELHARDT R, et al. Iron status of dialysis patients under rhuEPO therapy[J].Contrib Nephrol, 1990, 87: 78-86.
  • 7WAIGARD R.L, PARKER RA, ISMAIL N, et al. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin[J]. Am J Kidney Dis, 1995, 25(3): 433-439.
  • 8SILVERBERG DS, BLUM M, PEER G, et al. Intravenous ferric saccharate as an iron supplement in dialysis patients[J]. Nephron,1996, 72(3): 413-417.
  • 9MACDOUGALL IC, TUCKER B, THOMPSON J, et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin[J]. Kidney Int, 1996, 50(5): 1694-1699.
  • 10FISHBANE S, UNGUREANU V, MAESAKA JK, et al. The safety of intravenous iron dextran in hemodialysis patients[J]. Am J Kidney Dis, 1996, 28(4): 529-534.

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部